Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 108-113, January 2010

Characterizing resolution of catheter-associated upper extremity deep venous thrombosis

  • Mark A. Jones, MD

      Affiliations

    • Utah Vascular Center, Provo, Utah
  • ,
  • Dae Y. Lee, MD

      Affiliations

    • Oregon Health Sciences University, Portland, Ore
  • ,
  • Jocelyn A. Segall, MD

      Affiliations

    • Kaiser Permanente, Clackamas, Ore
  • ,
  • Gregory J. Landry, MD

      Affiliations

    • Oregon Health Sciences University, Portland, Ore
  • ,
  • Timothy K. Liem, MD

      Affiliations

    • Oregon Health Sciences University, Portland, Ore
  • ,
  • Erica L. Mitchell, MD

      Affiliations

    • Oregon Health Sciences University, Portland, Ore
  • ,
  • Gregory L. Moneta, MD

      Affiliations

    • Oregon Health Sciences University, Portland, Ore
    • Corresponding Author InformationCorrespondence: Gregory L. Moneta, MD, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, OP 11, Portland, OR 97239

Received 11 May 2009; accepted 29 July 2009. published online 02 November 2009.

Objective

Catheter-associated upper extremity deep venous thrombosis (CAUEDVT) is well known; however, resolution rates and factors affecting resolution of CAUEDVT are not well characterized. This study determined resolution rates and factors associated with resolution of CAUEDVT.

Methods

From January 1, 2002, to June 30, 2006, 1761 upper extremity venous duplex ultrasound (DU) studies were performed, and a new UEDVT was found in 253 (14.4%). Of these, 150 patients had routine follow-up and 101 had CAUEDVT. Demographics, follow-up DU results, and risk factors for venous thrombosis were recorded in the patients with follow-up studies and CAUEDVT. Univariate analysis and multivariate logistic regression analysis was performed to determine independent risk factors for complete thrombus resolution.

Results

There were 49 men (49%) and 52 women (51%) with CAUEDVT and follow-up studies. Mean age was 49 years (range, 5 months-80 years). Patients with CAUEDVT had risk factors for venous thrombosis that included malignancy in 34%, recent surgery/trauma in 34%, known hypercoagulable state in 11%, concomitant lower extremity DVT in 21%, and pulmonary embolism in 5%. Complete resolution of DVT on follow-up was documented in 46%. Thrombosis resolved in only 25% (6 of 24) when the catheter was not removed (P ≤ .05). Anticoagulation did not improve the rate of thrombus resolution (P ≤ 1.0) compared with catheter removal alone. Of the patients who had thrombus resolution, 75% resolved by 100 days (range, 1-914 days) after catheter removal ≤48 hours of diagnosis. In multivariate analysis, only catheter removal predicted the likelihood of thrombus resolution (odds ratio, 3.25; 95% confidence interval, 1.16-9.09; P = .025). New-site UEDVT developed in 86% of patients with CAUEDVT who underwent catheter removal and immediate catheter placement in a new site. Pulmonary embolism developed in five patients with CAUEDVT. Of these, three had documented lower extremity DVT as well. No pulmonary emboli were fatal.

Conclusions

More than half of CAUEDVT resolve ≤113 days when the catheter is removed ≤48 hours of diagnosis. New-site catheter placement has a high rate of new associated UEDVT. Anticoagulation does not appear to augment resolution of UEDVT.

 

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01688-7

doi:10.1016/j.jvs.2009.07.124

Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 108-113, January 2010